查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847711

电脑辅助检测市场按部署方式、最终用户、组件、显像模式和应用划分－2025-2032年全球预测

Computer Aided Detection Market by Deployment, End User, Component, Imaging Modality, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，电脑辅助检测市场将成长至 34.2737 亿美元，复合年增长率为 16.69%。

主要市场统计数据
基准年 2024 9.965亿美元
预计年份：2025年 11.6168亿美元
预测年份：2032年 3,427,370,000 美元
复合年增长率 (%) 16.69%

本文概述了演算法检测在临床影像中不断演变的作用，以及推动其在医疗保健服务环境中广泛应用的策略驱动因素。

电脑辅助检测已从实验室辅助手段发展成为提高诊断效率和临床决策支援的核心推动力。过去十年间，医学影像硬体和软体演算法的进步，使自动检测从一种小众研究工具发展成为诊断中心、医院和实验室的常用操作能力。随着影像吞吐量和成像方式的日益多样化，医疗专业人员越来越多地借助演算法辅助来缩短阅片时间、识别细微病变，并在分散的医疗环境中实现影像判读的标准化。

这种应用模式勾勒出现代格局，其中部署选择、临床工作流程整合以及监管环境的接受程度决定了检测工具从诊断到常规应用的转变速度。它还有助于理解基础设施偏好（无论是提供可管理扩展性的云端平台，还是优先考虑资料驻留的本地系统）如何影响采购和供应商选择。透过强调演算法演进、显像模式覆盖范围以及从肿瘤学到常规筛检的临床应用案例之间的相互关係，这种应用模式为决策者指明了推动应用和持续价值实现的策略槓桿。

了解正在重新定义发现软体如何融入临床护理和采购的关键技术、监管和商业性曲折点。

电脑辅助检测领域正经历着变革性的转变，其驱动力包括技术的成熟、医疗服务模式的转变以及监管期望的演变。首先，深度学习加速了演算法的复杂化，使得在CT和MRI等复杂成像模式下实现更精细的模式识别成为可能。云端平台为回顾性训练和前瞻性推理提供了弹性运算能力，而混合部署和本地部署在资料主权和延迟限制至关重要的场景下仍然具有吸引力。

同时，临床应用正受到报销和价值考量的推动，这些考虑将检测性能与可衡量的工作流程改进和患者预后联繫起来。放射科团队和肿瘤中心越来越重视解决方案的整合便捷性、解读便捷性以及对重症病例进行分诊的能力。最后，为了满足市场对可嵌入电子健康记录和PACS环境的端到端解决方案的需求，供应商的策略正围绕着将影像处理演算法与临床决策支援和连接性相结合的综合产品套件进行整合。这些转变强调整合性、临床检验和营运可扩展性是未来成功的关键决定因素。

了解近期关税和贸易动态如何重塑采购逻辑、供应商策略以及对模组化、互通解决方案的重视程度。

近期关税和贸易政策的变动为影像处理硬体和运算基础设施的采购和供应链规划带来了新的变数。对于依赖进口影像检测器、专用处理器或预先配置推理设备的系统而言，进口关税的提高会增加整体拥有成本并延长供应商的前置作业时间。因此，采购团队正在重新评估供应商，更加重视模组化和在地采购选项，同时仔细审查服务合约中保护买方免受供应链不稳定影响的条款。

除了直接的设备成本外，关税还会影响供应商的定价策略和策略性在地化决策。一些供应商正透过多元化製造地或与区域整合商合作来应对，以保持价格竞争力并维持服务水准。另一些供应商则透过放弃硬体捆绑销售、加快推出纯软体产品来最大限度地降低跨境关税的影响。同时，用户正在优先考虑云端原生部署和订阅授权模式，这种模式将授权与硬体采购週期脱钩。最终结果是，人们更加重视合约的灵活性，并重新强调互通性，从而使医疗服务提供者能够在不产生过高成本或影响临床连续性的情况下更换组件。

明确部署模式、最终使用者画像、组件差异、显像模式和临床应用如何决定开发和商业化优先顺序。

了解市场区隔有助于明确产品设计和商业化工作必须如何与使用者需求和技术限制相符。部署选项分为云端和本地部署管道，其中云端产品又根据平台服务和软体即服务 (SaaS) 进一步细分，而本地部署系统则根据永久授权和订阅模式进行区分。最终使用者细分涵盖诊断中心、医院和实验室，每个机构的工作流程量和检验要求各不相同。在医院中，肿瘤科和放射科尤其重要，这些科室需要精准的检测能力以及与多环节工作流程的整合。

组件细分将硬体、服务和软体分开。在软体方面，重点在于演算法效能，深度学习、传统机器学习和基于规则的方法在可解释性、训练资料需求和泛化能力方面各有优劣。显像模式细分突显了CT、MRI、PET、超音波和X射线等成像模式的独特需求，这些模式在解析度、造影机制和成像方式上的差异，对演算法设计和检验方法提出了不同的要求。最后，应用细分（包括乳腺癌、大肠直肠癌、肺癌和前列腺癌检测）突显了应用场景的临床异质性。这些细分共同为供应商指明了工程研发、临床证据产生和市场推广策略的优先顺序。

了解美洲、欧洲、中东和非洲以及亚太地区在监管、采购和临床方面的差异如何影响商业化和部署选择。

区域动态对产品采纳模式、监管管道和商业策略有显着影响。在美洲，医疗系统和私人影像网路倾向于快速采用检验的检测工具，这些工具能够展现工作流程效率并与电子病历系统无缝整合；同时，采购团队会密切评估与报销管道和临床医生工作效率相关的提案。相较之下，欧洲、中东和非洲的监管环境则较为复杂，各国卫生监管机构的要求和资料驻留规则使得企业需要采用更为精细的市场推广模式。供应商通常会寻求与当地整合商建立策略伙伴关係，并优先考虑与区域临床指南保持一致。

亚太地区庞大的影像处理需求以及公共混合的交付模式，为可扩展的云端部署或本地託管解决方案提供了机会，以满足监管和基础设施方面的限制。在所有地区，成功的关键在于根据当地患者群体客製化检验研究，确保语言和工作流程的在地化，并建立支援大规模部署的服务能力。从先导计画过渡到企业级部署，既需要技术适应能力，也需要对每个地区的采购习惯和临床重点有深刻的理解。

摘要了竞争格局，其中临床检验、整合能力和卓越服务决定了供应商的差异化和买家的选择。

竞争动态将取决于那些能够证明其产品已通过临床检验、具备强大的整合能力并能清楚展现营运价值的公司。领先的供应商通常会将演算法方面的专业知识与和影像处理硬体製造商、PACS供应商以及医疗IT整合商建立的牢固伙伴关係相结合，从而降低实施过程中的阻力。此外，那些提供实施支援、临床医生培训和绩效监控等服务的参与企业，透过确保持续的临床应用和可衡量的工作流程改进，在初始授权合约到期后仍能保持客户的黏着度。

新参与企业透过专注于特定应用和模式，并利用专有资料集和学术合作来建立差异化演算法，从而展开竞争。同时，成熟的影像处理供应商和云端服务供应商正利用其规模和平台能力，提供吸引企业买家的捆绑式解决方案。策略联盟和收购持续影响着这一竞争格局，大型公司寻求填补模式和应用方面的空白，而小型公司则寻求与领先的临床中心建立检验伙伴关係以提升信誉。对于买家而言，选择供应商越来越受到评估的驱动，这些评估不仅包括检测准确性，还包括售后支援、法规遵循以及共同开发客製化工作流程的能力。

向供应商和医疗机构推荐具体的策略重点，以加速产品应用、确保互通性并展现持久的临床和营运价值。

行业领导者应优先采取一系列切实可行的倡议，将循证实践与应用推广和持续价值联繫起来。首先，透过投资进行与支付方和医疗服务提供方采购委员会关注的终点指标相符的、严谨的临床检验研究，将技术绩效转化为可量化的临床和营运效益。其次，采用模组化架构，使软体能够在云端、混合云端和本地环境中运行，从而满足不同客户的需求，并降低供应链和关税的影响。

第三，与影像处理硬体供应商、IT整合商和临床中心建立牢固的伙伴关係关係，以加速技术应用并降低实施风险。第四，设计能够反映实际营运的定价和合约方案，例如按使用量付费的订阅模式或基于结果的交付模式，以降低技术应用门槛。最后，建立性能监控、临床医生反馈机制以及部署后持续学习能力，以保持演算法的有效性并展现其长期价值。透过实施这些建议，企业领导者可以将技术创新转化为持续的市场优势和更深入的临床整合。

详细介绍了一种透明的混合方法研究途径，该方法整合了相关人员访谈、临床文献和产品文檔，以使建议能够立足于实际操作层面。

研究途径结合了多学科依证和结构化的定性综合分析，以确保得出稳健且可操作的结论。透过对设备采购人员、放射科主任、影像技师和演算法开发人员的结构化访谈，我们获得了关于部署偏好、检验预期和操作痛点的观点。次要分析综合了关于演算法性能和特定成像方式技术限制的同行评审文献，并辅以监管指导文件和公开的临床试验註册数据，以评估证据基础的成熟度。

我们的调查方法着重于三角验证，将供应商的能力声明和产品文件与临床医生的回馈和用例进行比对，以识别实施方面的差距。在适当情况下，我们参考了技术白皮书和互通性规范，以检验有关整合和资料处理的说法。在整个研究过程中，我们强调可重复性和透明度，记录了受访相关人员的纳入标准、适用模式和用途的范围，以及在缺乏公开证据的情况下推断的局限性。这种混合方法确保了建议既反映了实际操作情况，也符合科学检验的现状。

最后，从综合角度探讨临床检验、互通性和适应性商业模式将如何决定检测解决方案的长期成功。

总之，电脑辅助检测融合了演算法进步、临床对可靠决策支援的需求，以及商业模式向灵活性和可验证价值倾斜的转变。其应用取决于供应商能否将演算法效能与无缝整合、可重复的临床证据以及符合当地监管和采购实际情况的灵活部署方案相结合。因此，决策者应从临床有效性、部署灵活性和上市后支援等多个方面评估解决方案，以确保其持续发挥作用。

能够将技术精准性与工作流程效率、诊断一致性和患者疗效等方面的可衡量改进联繫起来，并辅以降低准入门槛的定价和合约模式的供应商和服务商，将成为最终的赢家。透过将产品开发与专业用户、影像方式和当地医疗保健系统的细微需求相结合，相关人员可以充分发挥检测技术的优势，并将其融入现代诊断流程，使其成为值得信赖的组成部分。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于低剂量电脑断层扫描系统中早期肺癌检测的深度学习演算法
  • 整合基于云端基础的电脑辅助检测平台以进行远端放射学协作
  • 在医疗设备中实施边缘运算解决方案，以实现即时影像分析
  • 利用合成资料和生成对抗网路来增强模型训练资料集
  • 自主诊断软体的新兴报销框架与监管管道
  • 缓解演算法偏见并确保人工智慧驱动的医学影像工具公平性的策略
  • 与电脑辅助检测供应商和电子健康记录提供者伙伴关係，实现无缝的临床工作流程集成

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依部署方式分類的电脑辅助检测市场

  • 云
    • PaaS
    • SaaS
  • 本地部署
    • 永恆的
    • 订阅

9. 按最终使用者分類的电脑辅助检测市场

  • 诊断中心
  • 医院
    • 肿瘤学
    • 放射科
  • 研究所

第十章 电脑辅助检测市场（按组件划分）

  • 硬体
  • 服务
  • 软体
    • 演算法
      • 深度学习
      • 机器学习
      • 基于规则

11. 依显像模式的电脑辅助检测市场

  • CT
  • MRI
  • PET
  • 超音波
  • X射线

第十二章 电脑辅助检测市场依应用领域划分

  • 乳癌
  • 冒号
  • 肺
  • 摄护腺

第十三章 电脑辅助侦测市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 电脑辅助检测市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国电脑辅助检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Hologic, Inc.
    • GE HealthCare Technologies, LLC
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Fujifilm Holdings Corporation
    • International Business Machines Corporation
    • iCAD, Inc.
    • Volpara Health Technologies Limited
    • ScreenPoint Medical BV
    • Lunit Inc.
Product Code: MRR-385067DD9C86

The Computer Aided Detection Market is projected to grow by USD 3,427.37 million at a CAGR of 16.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 996.50 million
Estimated Year [2025] USD 1,161.68 million
Forecast Year [2032] USD 3,427.37 million
CAGR (%) 16.69%

Introduce the evolving role of algorithmic detection in clinical imaging and outline strategic drivers shaping adoption across healthcare delivery settings

Computer aided detection has matured from an experimental adjunct to a central enabler of diagnostic efficiency and clinical decision support. Over the past decade, advances in medical imaging hardware and software algorithms have converged to elevate automated detection from a niche research tool into an operational capability across diagnostic centers, hospitals, and research laboratories. As imaging throughput and modality diversity expand, providers increasingly rely on algorithmic assistance to reduce reading times, flag subtle pathology, and standardize interpretation across distributed care settings.

This introduction frames the contemporary landscape in which deployment choices, clinical workflow integration, and regulatory acceptance determine the pace at which detection tools move from pilot to routine use. It also situates the reader to understand how infrastructure preferences-whether cloud platforms offering managed scalability or on-premise systems prioritizing data residency-shape procurement and vendor selection. By highlighting the interplay between algorithm evolution, imaging modality coverage, and clinical use cases from oncology to routine screening, the introduction orients decision-makers to the strategic levers that will drive adoption and sustained value realization.

Describe the pivotal technological, regulatory, and commercial inflection points that together are redefining how detection software integrates into clinical care and procurement

The landscape of computer aided detection is undergoing transformative shifts driven by technological maturation, changing care delivery economics, and evolving regulatory expectations. First, algorithmic sophistication has accelerated through deep learning, enabling more nuanced pattern recognition across complex modalities such as CT and MRI, while also improving robustness in chest radiography and ultrasound. Second, the deployment conversation has shifted: cloud platforms now promise elastic compute for retrospective training and prospective inference, while hybrid and on-premise deployments retain appeal where data sovereignty and latency constraints matter.

Concurrently, clinical adoption is being propelled by reimbursement and value arguments that tie detection performance to measurable workflow gains and patient outcomes. Radiology groups and oncology centers increasingly evaluate solutions on integration ease, interpretability, and ability to triage high-acuity cases. Finally, vendor strategies are consolidating around comprehensive product suites that couple imaging algorithms with clinical decision support and connectivity, reflecting a market that favors end-to-end solutions capable of embedding into electronic health records and PACS environments. Taken together, these shifts emphasize integration, clinical validation, and operational scalability as the primary determinants of success moving forward.

Explain how recent tariff influences and trade dynamics are reshaping procurement logic, vendor strategies, and the emphasis on modular, interoperable solutions

Recent policy actions around tariffs and trade measures have introduced new variables into procurement and supply chain planning for imaging hardware and compute infrastructure. For systems that rely on imported imaging detectors, specialized processors, or preconfigured inference appliances, increased import duties can raise total cost of ownership and extend vendor lead times. Consequently, procurement teams are recalibrating vendor evaluations to emphasize modularity and local sourcing options, while service agreements are being scrutinized for clauses that insulate buyers from supply chain volatility.

Beyond direct device costs, tariffs influence vendor pricing strategies and strategic localization decisions. Some vendors respond by diversifying manufacturing footprints or partnering with regional integrators to preserve price competitiveness and maintain service levels. Others accelerate software-only offerings that pivot away from bundled hardware sales, thereby minimizing exposure to cross-border levies. In parallel, users are prioritizing cloud-native deployments or subscription licensing that decouple licensing from hardware procurement cycles. The net effect is heightened attention to contractual flexibility and a renewed emphasis on interoperability, enabling healthcare providers to swap components without incurring prohibitive costs or losing clinical continuity.

Reveal how deployment models, end-user profiles, component distinctions, imaging modalities, and clinical applications together define development and commercialization priorities

Understanding segmentation illuminates where product design and commercialization efforts must align with user needs and technical constraints. Deployment choices split between cloud and on-premise pathways, with cloud offerings further differentiated by platform service and software as a service approaches, while on-premise systems distinguish between perpetual licensing and subscription models; this dichotomy drives distinct expectations around maintenance, update cadence, and total lifecycle costs. End-user segmentation spans diagnostic centers, hospitals, and research laboratories, each with differing workflow volumes and validation requirements, and within hospital settings there is a particular focus on oncology and radiology specialties that demand targeted detection capabilities and integration with multidisciplinary workflows.

Component segmentation separates hardware, services, and software, and within software the focus narrows to algorithmic performance where deep learning, traditional machine learning, and rule-based approaches offer different trade-offs in explainability, training data needs, and generalizability. Imaging modality segmentation highlights modality-specific requirements across CT, MRI, PET, ultrasound, and X-ray, where resolution, contrast mechanisms, and acquisition variability impose unique algorithm design and validation approaches. Finally, application segmentation that includes breast, colorectal, lung, and prostate detection underscores the clinical heterogeneity of use cases: screening programs emphasize sensitivity and throughput, while diagnostic workflows prioritize specificity and detailed lesion characterization. Taken together, these segment lenses guide where vendors should prioritize engineering effort, clinical evidence generation, and go-to-market narratives.

Articulate how geographic regulatory, procurement, and clinical practice differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape commercialization and deployment choices

Regional dynamics materially influence adoption patterns, regulatory pathways, and commercial tactics. In the Americas, health systems and private imaging networks tend to favor rapid adoption of validated detection tools that can demonstrate workflow efficiency and integration with electronic records, while procurement teams closely assess reimbursement pathways and value propositions tied to clinician productivity. In contrast, the Europe, Middle East & Africa region presents a heterogeneous regulatory landscape where national health authority requirements and data residency rules require nuanced market entry models; vendors often pursue strategic partnerships with local integrators and prioritize conformity with regional clinical guidelines.

The Asia-Pacific region combines high volume imaging demand with a mix of public and private delivery models, creating opportunities for scalable cloud deployments as well as locally hosted solutions to meet regulatory and infrastructure constraints. Across all regions, success hinges on tailoring validation studies to local patient populations, ensuring linguistic and workflow localization, and building services capabilities that support deployments at scale. Transitioning from pilot projects to enterprise-grade installations requires both technical adaptability and a deep understanding of each region's purchasing practices and clinical priorities.

Summarize the competitive landscape where clinical validation, integration prowess, and service excellence determine vendor differentiation and buyer selection

Competitive dynamics are anchored by companies that can demonstrate clinical validation, robust integration capabilities, and a clear pathway to operational value. Leading vendors often combine algorithmic expertise with strong partnerships across imaging hardware manufacturers, PACS vendors, and health IT integrators to reduce friction at deployment. Additionally, service-oriented players that offer implementation support, clinician training, and performance monitoring create stickiness beyond initial license agreements by ensuring sustained clinical adoption and measurable workflow improvements.

New entrants compete by focusing on niche applications or modality specialization, leveraging proprietary datasets and academic collaborations to build differentiated algorithms. At the same time, established imaging vendors and cloud providers leverage scale and platform capabilities to offer bundled solutions that appeal to enterprise buyers. Strategic alliances and acquisitions continue to shape the competitive field, as larger players seek to fill modality or application gaps while smaller firms pursue validation partnerships with leading clinical centers to build credibility. For buyers, vendor selection increasingly evaluates not only detection accuracy but also post-sales support, regulatory readiness, and the capacity to co-develop bespoke workflows.

Recommend concrete strategic priorities for vendors and provider organizations to accelerate adoption, ensure interoperability, and demonstrate enduring clinical and operational value

Industry leaders should prioritize a set of actionable moves that translate evidence into adoption and sustained value. First, invest in clinically rigorous validation studies that align with the endpoints that matter to payers and provider procurement committees, thereby converting technical performance into quantifiable clinical and operational benefits. Second, embrace modular architectures that allow software to operate across cloud, hybrid, and on-premise environments to meet diverse customer constraints and to mitigate supply chain and tariff exposure.

Third, develop robust partnership models with imaging hardware vendors, IT integrators, and clinical centers to accelerate deployments and reduce implementation risk. Fourth, design pricing and contracting approaches that reflect operational realities-such as subscription models tied to usage or outcome-based provisions-to lower adoption barriers. Finally, build post-deployment capabilities for performance monitoring, clinician feedback loops, and continuous learning to maintain algorithmic relevance and to demonstrate longitudinal value. By executing these recommendations, leaders can convert technical innovation into durable market advantage and deeper clinical integration.

Detail a transparent mixed methods research approach that integrates stakeholder interviews, clinical literature, and product documentation to ground recommendations in operational reality

The research approach combined a multi-disciplinary evidence base and a structured qualitative synthesis to ensure robust, actionable conclusions. Primary insights derived from structured interviews with device procurement leads, radiology chiefs, imaging technologists, and algorithm developers provided perspective on deployment preferences, validation expectations, and operational pain points. Secondary analysis integrated peer-reviewed literature on algorithm performance and modality-specific technical constraints, complemented by regulatory guidance documents and publicly available clinical trial registries to assess evidence maturity.

The methodology emphasized triangulation: vendor capability statements and product documentation were cross-checked against clinician feedback and case studies to reveal implementation gaps. Where appropriate, technical white papers and interoperability specifications were referenced to validate claims about integration and data handling. Throughout the research, attention centered on reproducibility and transparency, documenting inclusion criteria for interviewed stakeholders, the scope of modality and application coverage, and the limits of inference where public evidence was sparse. This mixed-methods approach ensured that recommendations reflect both operational realities and the state of scientific validation.

Conclude with an integrative perspective on how clinical validation, interoperability, and adaptive commercial models will determine long term success for detection solutions

In conclusion, computer aided detection is positioned at the confluence of algorithmic progress, clinical demand for reliable decision support, and shifting commercial models that prioritize flexibility and demonstrable value. Adoption will continue to hinge on the ability of vendors to pair algorithmic performance with seamless integration, reproducible clinical evidence, and adaptable deployment options that respect regional regulatory and procurement realities. Decision-makers should therefore evaluate solutions on a composite of clinical validity, deployment flexibility, and post-market support to ensure sustained impact.

Looking ahead, the vendors and providers that win will be those who translate technical accuracy into measurable improvements in workflow efficiency, diagnostic consistency, and patient outcomes, supported by pricing and contracting models that lower the threshold for adoption. By aligning product development with the nuanced needs of specialty users, imaging modalities, and regional healthcare systems, stakeholders can realize the promise of detection technologies and embed them as reliable components of modern diagnostic pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of deep learning algorithms for early lung cancer detection in low-dose CT scanning systems
  • 5.2. Integration of cloud-based computer aided detection platforms for remote radiology collaboration
  • 5.3. Implementation of edge computing solutions to enable real-time image analysis in medical devices
  • 5.4. Expansion of synthetic data and generative adversarial networks to enhance model training datasets
  • 5.5. Emergence of reimbursement frameworks and regulatory pathways for autonomous diagnostic software
  • 5.6. Strategies for mitigating algorithmic bias and ensuring fairness in AI driven medical imaging tools
  • 5.7. Partnership between computer aided detection vendors and electronic health record providers for seamless clinical workflow integration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Computer Aided Detection Market, by Deployment

  • 8.1. Cloud
    • 8.1.1. Paas
    • 8.1.2. Saas
  • 8.2. On Premise
    • 8.2.1. Perpetual
    • 8.2.2. Subscription

9. Computer Aided Detection Market, by End User

  • 9.1. Diagnostic Centers
  • 9.2. Hospitals
    • 9.2.1. Oncology
    • 9.2.2. Radiology
  • 9.3. Research Labs

10. Computer Aided Detection Market, by Component

  • 10.1. Hardware
  • 10.2. Services
  • 10.3. Software
    • 10.3.1. Algorithm
      • 10.3.1.1. Deep Learning
      • 10.3.1.2. Machine Learning
      • 10.3.1.3. Rule Based

11. Computer Aided Detection Market, by Imaging Modality

  • 11.1. Ct
  • 11.2. Mri
  • 11.3. Pet
  • 11.4. Ultrasound
  • 11.5. X Ray

12. Computer Aided Detection Market, by Application

  • 12.1. Breast Cancer
  • 12.2. Colorectal
  • 12.3. Lung
  • 12.4. Prostate

13. Computer Aided Detection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Computer Aided Detection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Computer Aided Detection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Hologic, Inc.
    • 16.3.2. GE HealthCare Technologies, LLC
    • 16.3.3. Siemens Healthineers AG
    • 16.3.4. Koninklijke Philips N.V.
    • 16.3.5. Fujifilm Holdings Corporation
    • 16.3.6. International Business Machines Corporation
    • 16.3.7. iCAD, Inc.
    • 16.3.8. Volpara Health Technologies Limited
    • 16.3.9. ScreenPoint Medical B.V.
    • 16.3.10. Lunit Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. COMPUTER AIDED DETECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. COMPUTER AIDED DETECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPUTER AIDED DETECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLIO